{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:03:38Z","timestamp":1793448218117,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Enfants, cancers et Sant\u00e9","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00066-019-01461-6","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T01:02:33Z","timestamp":1554771753000},"page":"504-516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Adapted strategy to tumor response in childhood nasopharyngeal carcinoma: the French experience","Auf die Tumorreaktion angepasste Behandlungsstrategie beim Nasopharynxkarzinom in der Kindheit: Erfahrungen aus Frankreich"],"prefix":"10.1007","volume":"195","author":[{"given":"Ana\u00efs","family":"Jouin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Helfre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Bolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Claude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Laprie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Bogart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Vigneron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Potet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ducassou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Claren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois Georges","family":"Riet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Pierre","family":"Castex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Faure-Conter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice","family":"Fresneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Sophie","family":"Defachelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-139X","authenticated-orcid":false,"given":"Daniel","family":"Orbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"issue":"7","key":"1461_CR1","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/pbc.20106","volume":"43","author":"E Desandes","year":"2004","unstructured":"Desandes E, Lacour B, Sommelet D et\u00a0al (2004) Cancer incidence among adolescents in France. Pediatr Blood Cancer 43(7):742\u2013748","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"1461_CR2","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ijrobp.2008.12.030","volume":"75","author":"NL Downing","year":"2009","unstructured":"Downing NL, Wolden S, Wong P et\u00a0al (2009) Comparison of treatment results between adult and juvenile nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 75(4):1064\u20131070","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1461_CR3","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/pbc.21372","volume":"50","author":"D Orbach","year":"2008","unstructured":"Orbach D, Brisse H, Helfre S et\u00a0al (2008) Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects. Pediatr Blood Cancer 50(4):849\u2013853","journal-title":"Pediatr Blood Cancer"},{"key":"1461_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/MPH.0000000000001054","volume":"40","author":"ME Dourthe","year":"2018","unstructured":"Dourthe ME, Bolle S, Temam S et al (2018) Childhood Nasopharyngeal Carcinoma: State-of-the-Art, and Questions for the Future. J\u00a0Pediatr Hematol Oncol 40:85\u201392","journal-title":"J Pediatr Hematol Oncol"},{"issue":"10","key":"1461_CR5","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1002\/cncr.26528","volume":"118","author":"M Casanova","year":"2011","unstructured":"Casanova M, Bisogno G, Gandola L et\u00a0al (2011) A prospective protocol for nasopharyngeal carcinoma in children and adolescents: the Italian Rare Tumors in Pediatric Age (TREP) project. Cancer 118(10):2718\u20132725","journal-title":"Cancer"},{"issue":"9","key":"1461_CR6","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.ijporl.2013.06.005","volume":"77","author":"Z Yan","year":"2013","unstructured":"Yan Z, Xia L, Huang Y et\u00a0al (2013) Nasopharyngeal carcinoma in children and adolescents in an endemic area: a\u00a0report of 185 cases. Int J Pediatr Otorhinolaryngol 77(9):1454\u20131460","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"10","key":"1461_CR7","first-page":"525","volume":"32","author":"CJ Tao","year":"2013","unstructured":"Tao CJ, Liu X, Tang LL et al (2013) Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma. Chin. J\u00a0Cancer 32(10):525\u2013532","journal-title":"J Cancer"},{"key":"1461_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.oraloncology.2017.08.006","volume":"73","author":"SG Wu","year":"2017","unstructured":"Wu SG, Liao XL, He ZY et al (2017) Demographic and clinicopathological characteristics of nasopharyngeal carcinoma and survival outcomes according to age at diagnosis: A population-based analysis. Oral Oncol 73:83\u201387","journal-title":"Oral Oncol"},{"issue":"12","key":"1461_CR9","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1007\/s00405-017-4736-z","volume":"274","author":"FM Gioacchini","year":"2017","unstructured":"Gioacchini FM, Tulli M, Kaleci S et\u00a0al (2017) Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a\u00a0systematic review. Eur Arch Otorhinolaryngol 274(12):4091\u20134102","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"19","key":"1461_CR10","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1002\/cncr.27395","volume":"118","author":"M Buehrlen","year":"2012","unstructured":"Buehrlen M, Zwaan CM, Granzen B et al (2012) Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH\/DCOG. Cancer 118(19):4892\u20134900","journal-title":"Cancer"},{"issue":"2","key":"1461_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/pbc.26240","volume":"64","author":"P Sahai","year":"2017","unstructured":"Sahai P, Mohanti BK, Sharma A et\u00a0al (2017) Clinical outcome and morbidity in pediatric patients with nasopharyngeal cancer treated with chemoradiotherapy. Pediatr Blood Cancer 64(2):259\u2013266","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl 1","key":"1461_CR12","doi-asserted-by":"publisher","first-page":"E665","DOI":"10.1002\/hed.24066","volume":"38","author":"Q Guo","year":"2016","unstructured":"Guo Q, Cui X, Lin S et al (2016) Locoregionally advanced nasopharyngeal carcinoma in childhood and adolescence: Analysis of 95 patients treated with combined chemotherapy and intensity-modulated radiotherapy. Head Neck 38(Suppl 1):E665\u2013672","journal-title":"Head Neck"},{"issue":"8","key":"1461_CR13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.canrad.2013.06.046","volume":"17","author":"J Daoud","year":"2013","unstructured":"Daoud J, Ghorbal L, Siala W et\u00a0al (2013) Is there any difference in therapeutic results of nasopharyngeal carcinoma between adults and children? Cancer Radiother 17(8):763\u2013767","journal-title":"Cancer Radiother"},{"issue":"5","key":"1461_CR14","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/cncr.21258","volume":"104","author":"R Mertens","year":"2005","unstructured":"Mertens R, Granzen B, Lassay L et al (2005) Treatment of nasopharyngeal carcinoma in children and adolescents: definitive results of a\u00a0multicenter study (NPC-91-GPOH). Cancer 104(5):1083\u20131089","journal-title":"Cancer"},{"issue":"2","key":"1461_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00280-015-2933-2","volume":"77","author":"M Casanova","year":"2016","unstructured":"Casanova M, Ozyar E, Patte C et al (2016) International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5\u2011fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents. Cancer Chemother Pharmacol 77(2):289\u2013298","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"1461_CR16","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00432-017-2401-y","volume":"143","author":"WZ Qiu","year":"2017","unstructured":"Qiu WZ, Peng XS, Xia HQ et al (2017) A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma. J\u00a0Cancer Res Clin Oncol 143(8):1563\u20131572","journal-title":"J Cancer Res Clin Oncol"},{"key":"1461_CR17","first-page":"63","volume-title":"AJCC cancer staging handbook AJCC cancer staging manual","author":"S Edge","year":"2010","unstructured":"Edge S, Byrd D, Compton C et\u00a0al (2010) AJCC cancer staging handbook AJCC cancer staging manual, 7th\u00a0edn. Springer, New York, pp\u00a063\u201379","edition":"7"},{"issue":"1","key":"1461_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M et\u00a0al (1981) Reporting results of cancer treatment. Cancer 47(1):207\u2013214","journal-title":"Cancer"},{"issue":"9","key":"1461_CR19","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1684\/bdc.2010.1169","volume":"97","author":"Y Reguerre","year":"2010","unstructured":"Reguerre Y, Lacour B, Andre N et\u00a0al (2010) Epidemiology and management of rare paediatric tumours within the framework of the French Society for Children Cancer. Bull Cancer 97(9):1041\u20131045","journal-title":"Bull Cancer"},{"issue":"4","key":"1461_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/mpo.2950190415","volume":"19","author":"PR Brock","year":"1991","unstructured":"Brock PR, Bellman SC, Yeomans EC et\u00a0al (1991) Cisplatin ototoxicity in children: a\u00a0practical grading system. Med Pediatr Oncol 19(4):295\u2013300","journal-title":"Med Pediatr Oncol"},{"key":"1461_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J\u00a0Am Stat Assoc 53:467\u2013471","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"1461_CR22","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/cncr.20823","volume":"103","author":"C Rodriguez-Galindo","year":"2005","unstructured":"Rodriguez-Galindo C, Wofford M, Castleberry RP et al (2005) Preradiation chemotherapy with methotrexate, cisplatin, 5\u2011fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma. Cancer 103(4):850\u2013857","journal-title":"Cancer"},{"issue":"3","key":"1461_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1055\/s-0041-111180","volume":"228","author":"U Kontny","year":"2016","unstructured":"Kontny U, Franzen S, Behrends U et al (2016) Diagnosis and treatment of Nasopharyngeal carcinoma in children and adolescents\u2014recommendations of the GPOH-NPC study group. Klin Padiatr 228(3):105\u2013112","journal-title":"Klin Padiatr"},{"issue":"3","key":"1461_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.semradonc.2012.03.008","volume":"22","author":"AW Lee","year":"2012","unstructured":"Lee AW, Lin JC, Ng WT (2012) Current management of nasopharyngeal cancer. Semin Radiat Oncol 22(3):233\u2013244","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"1461_CR25","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00405-016-4154-7","volume":"274","author":"FM Gioacchini","year":"2017","unstructured":"Gioacchini FM, Tulli M, Kaleci S et\u00a0al (2017) Prognostic aspects in the treatment of juvenile nasopharyngeal carcinoma: a\u00a0systematic review. Eur Arch Otorhinolaryngol 274(3):1205\u20131214","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"1461_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0360-3016(03)00773-9","volume":"58","author":"S Laskar","year":"2004","unstructured":"Laskar S, Sanghavi V, Muckaden MA et\u00a0al (2004) Nasopharyngeal carcinoma in children: ten years\u2019 experience at the Tata Memorial Hospital, Mumbai. Int J Radiat Oncol Biol Phys 58(1):189\u2013195","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1461_CR27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0360-3016(99)00493-9","volume":"46","author":"SL Wolden","year":"2000","unstructured":"Wolden SL, Steinherz PG, Kraus DH et al (2000) Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer. Int J Radiat Oncol Biol Phys 46(4):859\u2013864","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1461_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.radonc.2006.08.019","volume":"81","author":"E Ozyar","year":"2006","unstructured":"Ozyar E, Selek U, Laskar S et al (2006) Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a\u00a0Rare Cancer Network study. Radiother Oncol 81(1):39\u201346","journal-title":"Radiother Oncol"},{"issue":"Suppl 1","key":"1461_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12070-013-0622-1","volume":"65","author":"B Guruprasad","year":"2013","unstructured":"Guruprasad B, Tanvir P, Rohan B et al (2013) Paediatric nasopharyngeal carcinoma: an 8\u2011year study from a\u00a0tertiary care cancer centre in South India. Indian J Otolaryngol Head Neck Surg 65(Suppl 1):131\u2013134","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"1","key":"1461_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/cncr.25376","volume":"117","author":"DK Cheuk","year":"2011","unstructured":"Cheuk DK, Billups CA, Martin MG et al (2011) Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma. Cancer 117(1):197\u2013206","journal-title":"Cancer"},{"issue":"1","key":"1461_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1040-8428(99)00003-7","volume":"31","author":"T Liu","year":"1999","unstructured":"Liu T (1999) Issues in the management of nasopharyngeal carcinoma. Crit Rev Oncol Hematol 31(1):55\u201369","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"1461_CR32","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ijrobp.2008.01.032","volume":"72","author":"S Laskar","year":"2008","unstructured":"Laskar S, Bahl G, Muckaden M et al (2008) Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 72(3):728\u2013736","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1461_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13014-014-0274-7","volume":"9","author":"W Liu","year":"2014","unstructured":"Liu W, Tang Y, Gao L et\u00a0al (2014) Nasopharyngeal carcinoma in children and adolescents\u2014a\u00a0single institution experience of 158 patients. Radiat Oncol 9:274","journal-title":"Radiat Oncol"},{"issue":"2","key":"1461_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/pbc.22521","volume":"55","author":"I Sultan","year":"2010","unstructured":"Sultan I, Casanova M, Ferrari A et\u00a0al (2010) Differential features of nasopharyngeal carcinoma in children and adults: a\u00a0SEER study. Pediatr Blood Cancer 55(2):279\u2013284","journal-title":"Pediatr Blood Cancer"},{"key":"1461_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1748-717X-9-71","volume":"9","author":"H Lin","year":"2014","unstructured":"Lin H, Huang S, Deng X et\u00a0al (2014) Comparison of 3D anatomical dose verification and 2D phantom dose verification of IMRT\/VMAT treatments for nasopharyngeal carcinoma. Radiat Oncol 9:71","journal-title":"Radiat Oncol"},{"issue":"17","key":"1461_CR36","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.ejca.2015.08.006","volume":"51","author":"MX Zhang","year":"2015","unstructured":"Zhang MX, Li J, Shen GP et al (2015) Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a\u00a0large cohort and long follow-up. Eur J Cancer 51(17):2587\u20132595","journal-title":"Eur J Cancer"},{"issue":"8","key":"1461_CR37","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.18632\/oncotarget.12736","volume":"8","author":"JL Chen","year":"2017","unstructured":"Chen JL, Huang YS, Kuo SH et al (2017) Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma. Oncotarget 8(8):14068\u201314077","journal-title":"Oncotarget"},{"issue":"3","key":"1461_CR38","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","volume":"104","author":"G Peng","year":"2012","unstructured":"Peng G, Wang T, Yang KY et al (2012) A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol 104(3):286\u2013293","journal-title":"Radiother Oncol"},{"issue":"2","key":"1461_CR39","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ijrobp.2008.05.065","volume":"72","author":"L Widesott","year":"2008","unstructured":"Widesott L, Pierelli A, Fiorino C et al (2008) Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys 72(2):589\u2013596","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"1461_CR40","doi-asserted-by":"publisher","first-page":"E1886","DOI":"10.1002\/hed.24341","volume":"38","author":"GD Lewis","year":"2016","unstructured":"Lewis GD, Holliday EB, Kocak-Uzel E et al (2016) Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes. Head Neck 38(Suppl 1):E1886\u20131895","journal-title":"Head Neck"},{"key":"1461_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1748-717X-3-4","volume":"3","author":"Z Taheri-Kadkhoda","year":"2008","unstructured":"Taheri-Kadkhoda Z, Bjork-Eriksson T, Nill S et al (2008) Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a\u00a0comparative treatment planning study of photons and protons. Radiat Oncol 3:4","journal-title":"Radiat Oncol"},{"issue":"3","key":"1461_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/MPH.0000000000000318","volume":"37","author":"PH Shaw","year":"2015","unstructured":"Shaw PH, Reed DR, Yeager N et\u00a0al (2015) Adolescent and young adult (AYA) oncology in the united states: a specialty in its late adolescence. J\u00a0Pediatr Hematol Oncol 37(3):161\u2013169","journal-title":"J Pediatr Hematol Oncol"},{"issue":"12","key":"1461_CR43","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/MPH.0b013e3181b91180","volume":"31","author":"S Downs-Canner","year":"2009","unstructured":"Downs-Canner S, Shaw PH (2009) A comparison of clinical trial enrollment between adolescent and young adult (AYA) oncology patients treated at affiliated adult and pediatric oncology centers. J\u00a0Pediatr Hematol Oncol 31(12):927\u2013929","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"1461_CR44","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/cncr.29869","volume":"122","author":"TH Keegan","year":"2016","unstructured":"Keegan TH, Ries LA, Barr RD et\u00a0al (2016) Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults. Cancer 122(7):1009\u20131016","journal-title":"Cancer"},{"issue":"3","key":"1461_CR45","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/pbc.25326","volume":"62","author":"T Cash","year":"2015","unstructured":"Cash T, Qayed M, Ward KC et\u00a0al (2015) Comparison of survival at adult versus pediatric treatment centers for rare pediatric tumors in an adolescent and young adult (AYA) population in the State of Georgia. Pediatr Blood Cancer 62(3):456\u2013462","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"1461_CR46","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","volume":"17","author":"Y Sun","year":"2016","unstructured":"Sun Y, Li WF, Chen NY et\u00a0al (2016) Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a\u00a0phase 3, multicentre, randomised controlled trial. Lancet Oncol 17(11):1509\u20131520","journal-title":"Lancet Oncol"},{"key":"1461_CR47","first-page":"CD004329","volume":"4","author":"B Baujat","year":"2006","unstructured":"Baujat B, Audry H, Bourhis J et\u00a0al (2006) Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma. Cochrane Database Syst Rev 4:CD4329","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1461_CR48","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","volume":"16","author":"P Blanchard","year":"2015","unstructured":"Blanchard P, Lee A, Marguet S et al (2015) Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol 16(6):645\u2013655","journal-title":"Lancet Oncol"},{"issue":"5","key":"1461_CR49","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1200\/JCO.2016.67.4119","volume":"35","author":"L Ribassin-Majed","year":"2017","unstructured":"Ribassin-Majed L, Marguet S, Lee AWM et al (2017) What is the best treatment of locally advanced Nasopharyngeal carcinoma? An individual patient data network meta-analysis. J\u00a0Clin Oncol 35(5):498\u2013505","journal-title":"J Clin Oncol"},{"issue":"21","key":"1461_CR50","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","volume":"26","author":"M Machtay","year":"2008","unstructured":"Machtay M, Moughan J, Trotti A et\u00a0al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J\u00a0Clin Oncol 26(21):3582\u20133589","journal-title":"J Clin Oncol"},{"issue":"3\u20134","key":"1461_CR51","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1615\/CritRevOncog.2018027528","volume":"23","author":"M Hong","year":"2018","unstructured":"Hong M, Tang K, Qian J et al (2018) Immunotherapy for EBV-Associated Nasopharyngeal Carcinoma. Crit Rev Oncog 23(3\u20134):219\u2013234","journal-title":"Crit Rev Oncog"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01461-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-019-01461-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01461-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T19:55:55Z","timestamp":1607198155000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-019-01461-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1461"],"URL":"https:\/\/doi.org\/10.1007\/s00066-019-01461-6","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"30 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.\u00a0Jouin, S.\u00a0Helfre, S.\u00a0Bolle, L.\u00a0Claude, A.\u00a0Laprie, E.\u00a0Bogart, C.\u00a0Vigneron, H.\u00a0Potet, A.\u00a0Ducassou, A.\u00a0Claren, F.G.\u00a0Riet, M.P.\u00a0Castex, C.\u00a0Faure-Conter, B.\u00a0Fresneau, A.S.\u00a0Defachelles, and D.\u00a0Orbach declare no actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations that could inappropriately influence (bias) their work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}